Common Stock, par value $0.001 per share
- Symbol
- MED
- Exchange
- NYSE
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.02, 9.01 · 8-K
Medifast, Inc.
MEDNYSEEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On October 26, 2026, Medifast, Inc. (the "Company") issued a press release announcing its earnings for the third quarter ended September 30, 2026. A copy of the press release is being furnished as Exhibit 99.1 attached hereto and is incorporated by reference herein.…
Press release in this filing
Medifast Announces Third Quarter 2026 Financial Results →Recent company filings
- 10-Q filingOct 26, 2026
- SCHEDULE 13D/A - filed by Steamboat Capital Partners, LLC regarding MEDIFAST INCAug 21, 2026
- SCHEDULE 13G/A - filed by Citadel Securities GP LLC regarding MEDIFAST INCAug 14, 2026
- SCHEDULE 13G - filed by SUSQUEHANNA SECURITIES, LLC regarding MEDIFAST INCAug 14, 2026
- S-8 filingAug 3, 2026
Registered securities in this filing
MEDIFAST, INC. · 8-K · Filed 2026-10-26
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item 2.02. Results of Operations and Financial Condition.
On October 26, 2026, Medifast, Inc. (the "Company") issued a press release announcing its earnings for the third quarter ended September 30, 2026.
A copy of the press release is being furnished as Exhibit 99.1 attached hereto and is incorporated by reference herein. This information is being furnished in this report and shall not be deemed to be "filed" for any purpose, including for the purpose of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1993, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.